PT  - JOURNAL ARTICLE
AU  - alipour, abbas
AU  - zarghami, mehran
AU  - sharifpour, ali
AU  - taghizadeh, fatemeh
TI  - Efficacy of smoking cessation in spirometry results of COPD smokers: a randomized controlled clinical trial
AID  - 10.1101/2020.04.29.20085894
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.29.20085894
4099  - http://medrxiv.org/content/early/2020/05/05/2020.04.29.20085894.short
4100  - http://medrxiv.org/content/early/2020/05/05/2020.04.29.20085894.full
AB  - Background Nicotine replacement therapy (NRT) may be more effective if it is combined with short cognitive-behavioral interventions for smoking cessation in chronic obstructive pulmonary diseasesmokers.Material and methods To examine the effectiveness of guided self-change (GSC), in a randomized controlled clinical trial, 57 men ranging from 45 to 77 years old were randomly assigned to three 19-member groups (GSC, NRT, and combined GSC-NRT).The primary data on smoking cessation and pulmonary functions were examined during 29 weeks using General Linear (GEE) Model status, intention-to-treat analysis, and repeated measures ANOVA test.Results A total of 9 (47.4%) of the participants in the GSC and combined groups and 4 (21.1%) participants in the NRT group reported total abstinence rate from smoking by the end of 29 weeks. Daily cigarette number was changed from 24 to 4 in GSC group, 26 to 11 in NRT group, and 20 to 6 in combined group. The GEE model revealed that this variable decreased in GSC group more than two other groups significantly (P=0.003). Moreover, the FVC level of the NRT group was lower than the GSC group (P=0.04), and the FEV in the NRT group was lower than GSC group (P=0.02). Furthermore, the level of FEV1/FVC act/pred in the NRT group was lower than GSC group (−6, 95% CI: -10.4-(−1.5), P=0.008) and it was also lower in the combined group than the GSC group (−6, 95% CI: -11.3-(−0.5), PV=0.03).Conclusion GSC and combined GSC-NRT treatments were equally effective in abstinence rate. Moreover Daily cigarette and the FEV1/FVC act/pred in GSC group was more than two other groups, indicating the health professionals can apply GSC alone in smoking cessation and improve lung function of COPD smokers.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIRCT201609271457N11; www.irct.irFunding StatementMazandaran University of Medical sciencesAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available when request